These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25575812)

  • 1. Identification of the oncogenic kinase TOPK/PBK as a master mitotic regulator of C2H2 zinc finger proteins.
    Rizkallah R; Batsomboon P; Dudley GB; Hurt MM
    Oncotarget; 2015 Jan; 6(3):1446-61. PubMed ID: 25575812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
    Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
    Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK1-mediated mitotic phosphorylation of PBK is involved in cytokinesis and inhibits its oncogenic activity.
    Stauffer S; Zeng Y; Zhou J; Chen X; Chen Y; Dong J
    Cell Signal; 2017 Nov; 39():74-83. PubMed ID: 28780319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
    Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
    Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis.
    Abe Y; Takeuchi T; Kagawa-Miki L; Ueda N; Shigemoto K; Yasukawa M; Kito K
    J Mol Biol; 2007 Jul; 370(2):231-45. PubMed ID: 17512944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global mitotic phosphorylation of C2H2 zinc finger protein linker peptides.
    Rizkallah R; Alexander KE; Hurt MM
    Cell Cycle; 2011 Oct; 10(19):3327-36. PubMed ID: 21941085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.
    Kim DJ; Li Y; Reddy K; Lee MH; Kim MO; Cho YY; Lee SY; Kim JE; Bode AM; Dong Z
    Cancer Res; 2012 Jun; 72(12):3060-8. PubMed ID: 22523035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
    Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T
    Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
    Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
    Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PBK/TOPK Expression Predicts Prognosis in Oral Cancer.
    Chang CF; Chen SL; Sung WW; Hsieh MJ; Hsu HT; Chen LH; Chen MK; Ko JL; Chen CJ; Chou MC
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
    Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
    Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
    Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
    Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOPK and PTEN participate in CHFR mediated mitotic checkpoint.
    Shinde SR; Gangula NR; Kavela S; Pandey V; Maddika S
    Cell Signal; 2013 Dec; 25(12):2511-7. PubMed ID: 24012691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains.
    Dovat S; Ronni T; Russell D; Ferrini R; Cobb BS; Smale ST
    Genes Dev; 2002 Dec; 16(23):2985-90. PubMed ID: 12464629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.
    Diao X; Yang D; Chen Y; Liu W
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.
    Zhu K; Cheng X; Wang S; Zhang H; Zhang Y; Wang X; Chen Y; Wu J
    Front Endocrinol (Lausanne); 2021; 12():706909. PubMed ID: 35126305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.
    Liu Y; Liu H; Cao H; Song B; Zhang W; Zhang W
    Oncol Rep; 2015 Dec; 34(6):3288-96. PubMed ID: 26503118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells.
    Nandi A; Tidwell M; Karp J; Rapoport AP
    Blood Cells Mol Dis; 2004; 32(1):240-5. PubMed ID: 14757441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.